---
title: "Cosunter and ZZPZH established a pharmaceutical company with a registered capital of 50 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261186669.md"
description: "According to Tianyancha's business information, recently, Guangsheng Hehuang Pharmaceutical Co., Ltd. was established, with Huang Xiaohang as the legal representative and a registered capital of 50 million RMB. The business scope includes drug wholesale, food sales, health food sales, internet sales of food, sales of special medical purpose formula foods, cosmetics wholesale, daily miscellaneous goods sales, and investment activities with its own funds. Shareholder information shows that the company is held by Guangsheng Tang and Fujian Pianzaihuang Health Technology Co., Ltd., a subsidiary of Pianzaihuang, with respective shares of 51% and 49%"
datetime: "2025-10-15T06:31:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261186669.md)
  - [en](https://longbridge.com/en/news/261186669.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261186669.md)
---

# Cosunter and ZZPZH established a pharmaceutical company with a registered capital of 50 million

According to Tianyancha's business information, recently, Guangsheng Hehuang Pharmaceutical Co., Ltd. was established, with Huang Xiaohang as the legal representative and a registered capital of 50 million RMB. The business scope includes drug wholesale, food sales, health food sales, internet sales of food, sales of special medical purpose formula foods, cosmetics wholesale, daily miscellaneous goods sales, and investment activities with its own funds. Shareholder information shows that the company is held by Guangsheng Tang and Fujian Pianzaihuang Health Technology Co., Ltd., a subsidiary of Pianzaihuang, with respective shares of 51% and 49%

### Related Stocks

- [300436.CN](https://longbridge.com/en/quote/300436.CN.md)
- [600436.CN](https://longbridge.com/en/quote/600436.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Google's latest AI push runs the risk of upsetting an important group that's starting to resent the tech](https://longbridge.com/en/news/287076382.md)
- [15:37 ETMuse Communications Celebrates 10 Years of Award-Winning Legal Marketing and Public Relations](https://longbridge.com/en/news/286811115.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)